We provide cutting edge point-of care diagnostic technologies.
Platforms that can run multiple immunofluorescence chromatography assays – including for active COVID-19 infection and IgG / IgM.
100% Concordance with PCR
In independent clinical trials, the AFS-1000 with the COVID-19 cassette agreed 100% with all positive clinical samples to a Ct value of 39 on PCR.
How do we measure accuracy?
Most manufacturers brag about sensitivity and specificity.
But that’s not the whole picture. Those are of little use if a test only identifies people with the highest levels of virus.
Sensitivity is the ability of a test to correctly identify patients with a disease.
Specificity is the ability of a test to correctly identify patients without the disease.
How much virus needs to be in the sample for a reliably positive result.
News
MFX COVID Test Beats MHRA Target Product Profile
MFX Biotech test beats the highest MHRA standard for point-of-care rapid COVID testing
NEW | COVID Neutralising Antibody Test
New neutralising antibody test detects antibodies against the viral 'S' protein - the same antibodies elicited by current vaccines
MFX Endorsed by TV and Film Industry
Our COVID testing solution has been endorsed by a key industry body and we're already in production!
A game-changing innovation in COVID-19 testing.
A game-changing innovation in COVID-19 testing.
Only diagnoses active infections: no false positives due to past infections – unlike PCR and LAMP
Paul Matthews
Paul has more than twenty years’ experience in various commercial roles. His background includes senior positions in Forex, marketing, aviation, and business management.
Simon Lane
Simon has a wealth of board experience in an eclectic mix of industries from biotech to precious metals to FMCG. Simon leads the MFX client exerience team and relishes the complex challenges that COVID-19 testing presents.
Contact Us
Please get in touch and one of our team will be in contact. No pushy salesmen – promise – we just let the science do the talking.